Leerink Partners Cuts Price target on Diplomat Pharmacy (DPLO) Following Weak EPS Guide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to Leerink Partners Cuts Price target on Diplomat Pharmacy (DPLO) Following Weak EPS Guide
February 29, 2016 6:07 PM EST
Rockwell Medical Technologies (NASDAQ: RMTI) 27.6% LOWER; reported Q4 EPS of ($0.12), $0.14 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $19.98 million.
Diplomat Pharmacy (NYSE: DPLO) 25.6% LOWER; reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $987 million versus the consensus estimate of $969.7 million. GUIDANCE: Diplomat Pharmacy sees FY2016 EPS of $0.84-$0.89, versus the consensus of $1.00. Diplomat Pharmacy sees FY2016 revenue of $4.3-4.6... More
February 29, 2016 4:16 PM EST
Diplomat Pharmacy (NYSE: DPLO) reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $987 million versus the consensus estimate of $969.7 million.
GUIDANCE:
Diplomat Pharmacy sees FY2016 EPS of $0.84-$0.89, versus the consensus of... More
February 26, 2016 3:19 PM EST
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
3D Systems (NYSE: DDD) - consensus EPS $0.03
AMC Entertainment (NYSE: AMC) - consensus EPS $0.40
Acadia Pharma (Nasdaq: ACAD) - consensus loss $0.38
Altisource Residential (NYSE: RESI) - consensus EPS $0.18
Ares Management (Nasdaq: ARES) - consensus EPS $0.29
Arqule (Nasdaq: ARQL) - consensus loss... More
